- Durability of efavirenz compared with boosted protease inhibitor-based regimens in antiretroviral-naïve patients in the Caribbean and central and South America. Open Forum Infectious Diseases. 2018 Academic Article GET IT
A picture is worth a thousand words: Maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts.
Journal of the International AIDS Society.
Times cited: 3
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements from an International Expert Panel.
Clinical Infectious Diseases.
Times cited: 7
CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean.
Open Forum Infectious Diseases.
Times cited: 2